Colorectal cancer (CRC) represents the second leading cause of cancer-related deaths
worldwide. The pathogenesis of CRC is a complex multistep process. Among other factors …

The gastrointestinal tract harbors most of the microbiota associated with humans. In recent
years, there has been a surge of interest in assessing the relationships between the gut …

Inflammatory bowel disease (IBD)-related colorectal cancer (CRC) is responsible for
approximately 2% of the annual mortality from CRC overall, but 10–15% of the annual …

Luteolin belongs to the family of flavonoids, which have anti‐inflammatory functions,
potentially useful in a clinical context, particularly for patients suffering from cancer …

Background: The aim of this study was to clarify the effect of 5-aminosalicylic acid (5-ASA)
treatment on gut bacterial microbiota in patients with ulcerative colitis (UC). Methods: A total …

Colorectal cancer is the third largest cancer in worldwide and has been proven to be closely
related to the intestinal microbiota. Many reports and clinical studies have shown that …

The gut microbiota consists of a dynamic multispecies community of bacteria, fungi, archaea,
and protozoans, playing a fundamental role in the induction, training, and function of the …

There is wide evidence that CRC could be prevented by regular physical activity, kee** a
healthy body weight, and following a healthy and balanced diet. Many sporadic CRCs …

Simple Summary Colorectal cancer (CRC) is one of the most serious potential complications
of inflammatory bowel diseases (IBDs). The aging of patients affected by IBDs makes this …

The human gastrointestinal tract is estimated to be colonised by over 1014 bacteria,
approximately 10-fold of the total number of cells in the human body. Recently, an important …